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Mechanisms that initiate and control the natural hypometabolic states of 
mammals are poorly understood. The laboratory developed a model of deep 
hypometabolism (DH) initiated by uptake of 5’-adenosine monophosphate (5’-AMP) 
into erythrocytes. Mice enter DH when given a high dose of 5’-AMP and the body 
cools readily. Influx of 5’-AMP appears to inhibit thermoregulatory control. In a 15°C 
environment, mice injected with 5’-AMP (0.5 mg/gw) enter a Phase I response in 
which oxygen consumption (VO2) drops rapidly to 1/3rd of euthermic levels. The 
Phase I response appears independent of body temperature (Tb). This is followed 
by gradual body temperature decline that correlates with VO2 decline, called Phase 
II response. Within 90 minutes, mouse Tb approaches 15°C, and VO2 is 1/10th of 
normal. Mice can remain several hours in this state, before gradually and safely 
recovering. The DH state translates to other mammalian species. Our studies show 
uptake and metabolism of 5’-AMP in erythrocytes causes biochemical changes that 
initiate DH. Increased AMP shifts the adenylate equilibrium toward ADP formation, 
consequently decreasing intracellular ATP. In turn, glycolysis slows, indicated by 
increased glucose and decreased lactate. 2,3-bisphosphoglycerate levels rise, 
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allosterically reducing  oxygen affinity for hemoglobin, and deoxyhemoglobin rises. 
Less oxygen transport to tissues likely triggers the DH model.  
The major intracellular pathway for AMP catabolism is catalyzed by AMP 
deaminase (AMPD). Multiple AMPD isozymes are expressed in various tissues, but 
erythrocytes only have AMPD3. Mice lacking AMPD3 were created to study control 
of the DH model, specifically in erythrocytes. Telemetric measurements 
demonstrate lower Tb and difficulty maintaining Tb under moderate metabolic stress. 
A more dramatic response to lower dose of 5’-AMP suggests AMPD activity in the 
erythrocyte plays an important role in control of the DH model. Analysis of 
adenylates in erythrocyte lysate shows 3-fold higher levels of ATP and ADP but 
similar AMP levels to wild-type.  
Taken together, results indicate alterations in energy status of erythrocytes 
can induce a hypometabolic state. AMPD3 control of AMP catabolism is important 
in controlling the DH model. Genetically reducing AMP catabolism in erythrocytes 
causes a phenotype of lower Tb and compromised ability to maintain temperature 
homeostasis.  
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Chapter 1 
Overview of natural hypometabolism and 
therapeutic hypothermia 
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Overview of natural methods of energy conservation 
Mammals and birds have high metabolic rates and generate large amounts 
of heat even while at rest, allowing them to maintain a constant core body 
temperature (Tb) of about 37°C. They can maintain normal Tb (euthermia) despite 
losing body heat to a cold environment, by increasing heat production. This trait 
comes at high energy cost and allows mammals and birds to live in extreme 
environments including below freezing temperatures (1).  
Some mammals and birds can undergo hypometabolic periods that allow 
energy conservation. Most mammals experience shallow oscillations in metabolic 
rate by up to 20% during the 24 hour rhythm of rest and activity. There is a 
corresponding fluctuation in Tb, ranging from 0.5 to 2°C. Birds experience more 
pronounced oscillations in metabolic rate and Tb (1).  
In addition to the 24 hourly rhythm, many mammals and birds can undergo 
extended periods of hypometabolism and reduced Tb. Some mammals experience 
a daily temporary decline in metabolic rate and Tb, called daily torpor, often in 
response to changes in photoperiod, decreased food availability, and colder 
ambient temperature (Ta) (2). In response to lack of water in warm environments, 
reptiles and amphibians undergo aestivation, which is a hypometabolic state similar 
to torpor but without the decrease in Tb (3). Aestivation is rare in mammals, the best 
described is the fat-tailed dwarf lemur in the tropics (4). Some mammals 
undergo a seasonal extended period of deep torpor bouts, called hibernation. In 
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daily torpor, aestivation and hibernation, metabolic rate can be reduced to a fraction 
of the basal rate (1).  
Among the diverse species of mammals, many orders, including carnivora, 
primates, and rodentia have members that either hibernate or undergo daily torpor. 
A large range of sizes of mammals can enter such hypometabolic states, from 
shrews to bears. Hibernation experts suggest that this means all mammals share a 
widespread ability to enter a hypometabolic state (1). 
 During hibernation an animal’s metabolic rate and Tb decreases in torpor 
bouts that can last for several weeks, with periodic arousals to euthermia lasting 
about one day. Small hibernators such as bats, marmots and ground squirrels, can 
undergo a dramatic decrease in Tb, reaching temperatures close to or below 
freezing. The metabolic rate of these small hibernators decreases to approximately 
2-5% of basal metabolic rate (5). However, a much larger hibernating mammal such 
as the bear undergoes a less dramatic change in Tb and metabolic rate. For this 
reason, investigators in the hibernation field debated whether bears are true 
hibernators. Recently, continuous telemetry and metabolic rate monitoring 
performed in black bears led to the conclusion that they do hibernate. Bear Tb 
declines from 37°C to a low of 30°C, with an average temperature of 33°C. 
Metabolic rate of bears decreases to between 53 – 65% of normal rate (5). Even 
tropical primates can hibernate. The fat-tailed dwarf lemur of Madagascar lives on 
fruits and arthropods in the dry deciduous forest of Kirindy. During the dry season 
the animals hibernate or aestivate in tree holes in response to food and water 
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shortage. The Tb of these animals can fluctuate widely, depending on the Ta, and 
they remain hypometabolic even when the Ta is above 30°C (4).  
 The mechanisms that initiate hypometabolic states such as torpor, 
aestivation and hibernation are poorly understood. Environmental conditions that 
can trigger these states are short photoperiod, cold Ta (in torpor), warm Ta (in 
aestivation), and less food and water availability. Animals such as deer mice and 
hamsters enter torpor in response to short photoperiod, even with free access to 
food and water. However, food shortage can induce torpor in these animals during 
any season (6). For decades investigators have tried to determine the molecular 
and biochemical conditions that cause animals to enter such hypometabolic states.  
 Investigators have identified a complex of four proteins called hibernation-
specific protein complex (HPc) that is a candidate hormone for control of 
hibernation. It is produced in the liver, enters the bloodstream, and its expression 
and transport into the brain are regulated by endogenous circannual rhythms (7).  In 
chipmunks, levels of HPc begin to decline in blood, and begin a simultaneous 
increase in cerebrospinal fluid, prior to onset of hibernation. Levels remain low in 
blood and peak in cerebrospinal fluid during the hibernation phase. At the end of 
hibernation, HPc levels rise in blood and decline in cerebrospinal fluid. The 
circannual changes in HPc levels are independent of changes in body temperature, 
which raised questions to its correlation with the animal’s metabolic state (8). 
 Interestingly, in European hamsters it was found that the circadian clock is 
stalled during deep torpor. The mRNA levels of three of the genes involved in the 
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transcriptional feedback loop that drives the circadian clock were compared in 
euthermic and hibernating hamsters. In contrast to the normal oscillation of mRNA 
levels of Per1, Per2, and Bmal1 in euthermic animals, the transcripts in the 
hibernating animals remained at steady levels, showing that the circadian clock was 
no longer oscillating (9). However, the circadian clock appears to regulate the timing 
of torpor behavior. It was shown that ablation of the hypothalamic suprachiasmatic 
nucleus, the structure of the brain that is the pacemaker for the circadian clock, 
changes timing of hibernation in ground squirrels (10).  
Energy utilization in natural hypometabolic states 
Energy sources were studied in Djungarian hamsters in torpor. It was found 
that during the beginning of a torpor bout the animals primarily used carbohydrates 
for energy, but that as the torpor bout progressed there is a progression towards 
lipid metabolism as their primary energy source. (11).  
Control of body temperature by the hypothalamus 
The preoptic area of the hypothalamus is thought to play a central role in 
regulating Tb. When Tb decreases, the preoptic area sends a signal to the 
vasomotor center in the medulla to trigger an autonomic response that decreases 
the diameter of peripheral blood vessels. In turn, this reduces blood flow to the skin, 
which reduces the rate of heat loss to the environment (12).  However, if the 
vasomotor center is inhibited, peripheral vasodilation occurs, and the increased 
blood flow to the skin causes heat loss to the environment. When the blood flow 
increases, the sweat glands are stimulated, and this increases evaporative heat 
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loss. In addition, respiration rate is increased, which also causes heat loss through 
evaporation (12). All these changes that control the Tb are thought to be triggered 
by the preoptic area of the hypothalamus.  
Cold and warm-sensitive neurons exist in the hypothalamus. Mice over-
expressing the uncoupling protein 2 in hypocretin neurons were found to have 
elevated temperature in the hypothalamus. These mice displayed a phenotype of 
lower Tb by 0.3 – 0.5°C compared to wild-type littermates (13). 
Thermogenesis by uncoupling oxidative phosphorylation 
 Uncoupling proteins act to uncouple the oxidation (electron transport chain) 
from the phosphorylation (generating ATP from ADP) in oxidative phosphorylation 
(14). The classical uncoupling protein, UCP1, is located in the inner membrane of 
mitochondria in brown adipose tissue. It uses oxygen to combust substrate, and 
releases heat without producing ATP. This allows non-shivering thermogenesis 
(14). Adult humans and most large adult mammals do not have much brown 
adipose tissue, but it is found in many adult small mammals and in newborn 
mammals (14, 15). Uncoupling of oxidative phosphorylation is known to generate 
heat to maintain Tb in many hibernating mammals, mammals adapted to cold Ta, 
and in newborn mammals (16). Other uncoupling proteins, UCP2 and UCP3 have 
been identified in other tissues, but there is ongoing debate about their roles in 
thermogenesis (15). 
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Artificial induction of hypometabolism 
While the initiation mechanism of hypometabolism seen in hibernation and 
torpor is still unknown, glucose metabolism appears to play a role. Siberian 
hamsters can be induced into torpor by injection of 2-deoxyglucose (2-DG), a 
metabolic inhibitor (17). 2-DG is a non-metabolizable analog of glucose that inhibits 
the first enzyme in the glycolytic pathway, hexokinase. The length of the torpor 
bouts can be modulated with short photoperiods. These observations implicate the 
cellular production of ATP to be important for torpor. However, injection of a 
different metabolic inhibitor, β-mercaptoacetate, which inhibits fatty acid oxidation in 
mitochondria, does not induce torpor in these animals (17). These observations 
suggest that the glycolytic pathway appears to play a key role in the induction of 
torpor. In contrast, fatty acid oxidation does not appear to play a role in the 
induction.  
Another substance used to induce a torpor state in animals is 3-
iodothyronamine, a naturally occurring metabolite of T4, which is the most active  
form of thyroid hormone. When rodents were given a large dose of 3-
iodothyronamine, they entered a hypometabolic state and had lowered heart rate. 
Research is ongoing to determine the mechanism, which has been shown to be 
active without entry into the brain. G-protein coupled receptor signaling is believed 
to be involved (18, 19).  
Microinjection of adenosine into the anteroventral preoptic region of the brain 
was shown to induce hypothermia and simultaneous hypoxia-induced 
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hyperventilation in rats. This mechanism is believed to act through the A1 adenosine 
receptor, because injection of an A1 receptor – specific antagonist attenuated these 
effects (20). 
A model of “suspended animation” was developed in non-hibernating 
mammals that is induced by inhalation of H2S gas. In the H2S model, animals enter 
a hypometabolic state and lose ability to thermoregulate (21, 22). The H2S gas 
induction of hypometabolism is thought to be through its inhibition of cytochrome c 
oxidase activity. However, H2S gas is known to be rapidly taken up by the red blood 
cells and has been shown to dissociate oxygen from hemoglobin in the reaction 
HbO2 + 2H2S = Hb + 2H2O + 2S (23).  
Another method investigators have used to induce hypometabolism and 
dramatically decrease Tb in non-hibernating mammals is exsanguination. In this 
method, replacement of blood with a saline solution can successfully and reversibly 
reduce Tb of dogs to near freezing (24). 
 Although mechanisms of hibernation and torpor in the wild are not fully 
understood, protective benefits of lowered body temperature and metabolic rate are 
observed. For example, animals in hibernation do not suffer the harmful effects of 
ischemia despite dramatic decreases in blood flow to tissues (25).   
Therapeutic Hypothermia in the Clinic 
Clinicians employ these protective benefits by artificially reducing body 
temperature and metabolic rate in medical trauma cases. Therapeutic hypothermia 
attenuates further injury in patients who have suffered stroke or myocardial 
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infarction. It is also used during surgeries such as transplant, cardiac bypass, and 
aortic repair to prevent ischemia-reperfusion injury, a common complication 
following major surgery (26).  
Although more doctors have begun using therapeutic hypothermia in the past 
decade, the methods are still considered risky because the patient’s body naturally 
fights the decrease in body temperature, requiring administration of paralytic and 
sedative drugs. The drug effects make it difficult to properly assess and treat the 
patient (27). This challenge has prompted researchers to look for safer methods of 
inducing hypothermia.  
 The goal of this dissertation is to describe my research on our laboratory’s 
model of 5’-AMP – induced deep hypometabolism. It will describe investigations to 
determine the role of 5’-AMP in the model, the site of initiation, and an aspect of 
metabolic control of the model. This body of work contributes to the understanding 
of the mechanisms of the model, which has possible potential for therapeutic use in 
humans. 
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Chapter 2 
Experimental Procedures 
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Creation of AMPD3 deficient mice 
ES cells containing the vector to make the AMPD3 deficient mice were 
purchased from Knockout Mouse Project (KOMP), University of California, Davis, 
CA. The vector was designed using the strategy for “knockout-first” alleles 
described by the Stewart lab (28). The vector used the “knockout-first” technology to 
insert the cassette into intron 1 before the essential exon (exon 2) of AMPD3 locus 
to create a missense mutation that would result in a non-functional mRNA transcript 
(Figure 1). The ES cells were originally produced by Lexicon (now Lexicon 
Pharmaceuticals, Inc.), The Woodlands, TX, and then sold to KOMP. The ES cells 
(C57Bl/6 background) were sent to the Transgenic and Stem Cell Service Unit of 
the Brown Institute of Molecular Medicine, Houston, TX, for microinjection and 
generation of chimeras. Eight male chimeras (C57Bl/6 wild-type, Balbc AMPD3 
knockout) were generated, and all were mated with C57Bl/6 wild-type females 
purchased from Harlan Laboratories, Houston, TX. Of the 8 chimeras, 2 were able 
to produce germline transmission to create AMPD3 +/- mice, which were then mated 
to produce the AMPD3 +/+, +/- and -/- mice used in experiments.  
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Figure 1: The targeting vector design for AMPD3 knockout 
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ES Cell Clone (C57Bl/ 6 background)
Targeting vector – conditional (frameshift)
3' homology arm
(5954bp) 
5' homology arm
(4607bp)
Knock-in vector into exon 2
3’ homology arm is in exon 3 and exon 4 
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Metabolic Chamber description and use 
For metabolic chamber experiments, mice were housed in a climate-
controlled metabolic chamber designed for mouse studies, the Comprehensive Lab 
Animal Monitoring System (CLAMS), Columbus Instruments, Columbus, OH. It has 
16 cages inside a precisely controlled temperature unit (temperature range 2 - 
50°C, +/- 1°C). Each animal is housed individually in an airtight cage, and O2 and 
CO2 going in and out of the cage is measured by high speed gas sensors on an 
Open Circuit Oxymax Calorimeter, (Columbus Instruments, Columbus, OH). The 
airflow into and out of the cage is calibrated against a known gas mixture before 
each experiment. To avoid contamination of the sampled air, the sample flows 
through Drierite to capture moisture, and ammonia filters capture urea. Samples are 
taken every minute, cage by cage, with one extra minute for calibration, so if all 16 
cages are used, then air in each cage is sampled every 17 minutes.  Receivers on 
the sides of each cage can collect telemetry data, which is measured at the same 
frequency as the gas sensing. In some of the experiments, animals were implanted 
with telemetry chips (G2 E-mitter, Mini-Mitter Respironics, Bend, OR). The cages 
allow free access to food and water. Food consumption can be measured by 
crushing the mouse chow pellets. The food hopper is on a scale, and as food is 
removed, the negative balance is recorded. Length and frequency of feeding bouts 
are also recorded.  
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Surgical Implantation of Telemetry Chips into Mice 
Telemetry chips are sterilized via ethylene oxide gas. Animals are 
anesthetized via isoflurane gas mask to surgical plane of anesthesia. One dose of 
antibiotic (Baytril, 5 mg/kg, s.q.) is injected at the incision site. One dose of 
analgesia (Buprenorphine, 0.1 mg/kg, s.q.) is injected. The ventral surface of the 
abdomen is clipped free of hair, and the animal is secured to a heated surgical 
surface with adhesive tape. The shaved area is disinfected with Betadine. One dose 
of local analgesic (0.25% Marcaine, < 1 ml/kg) is injected at the incision site. A 
midline abdominal skin incision of no more than 2 cm is made 1 cm below the 
diaphragm. Then the abdomen is opened by making a 2 cm incision along the linea 
alba of fascia where the abdominal muscles join the midline. The intestines and 
colon are gently reflected and the e-mitter is positioned in the abdominal cavity 
along the saggital plane, placed in front of the caudal arteries and veins but dorsal 
to the digestive organs. Non-absorbable nylon suture is passed through the silastic 
tubing in the outer wall of the e-mitter capsule. The capsule is sutured to the body 
wall to reduce migration of the e-mitter inside the body, and provide a more 
accurate temperature reading. Organs are replaced, intestines and colon are 
examined for kinks, and then the abdominal opening is closed with 5-0 Vicryl 
absorbable suture material using a continuous interlocking running stitch. Then the 
skin is closed with nylon suture material using interrupted mattress stitches. Then 
the animal is removed from anesthesia, and given pain relief as needed and 
monitored for the recovery period. Animals are not used in experiments until two 
weeks after the surgery and they show signs of full recovery.  
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AMP Deaminase Activity Assay 
This protocol was adapted from a protocol of Dr. Richard Sabina, University 
of Wisconsin Medical School (e-mail correspondence). AMPD activity is quantified 
by measuring formation of IMP when protein sample is added to a reaction mixture 
with saturated amount of substrate (AMP). 20 ug soluble protein is placed in a 1.5 
ml tube and the following reaction mixture is added: 25 mM imidazole, pH 7.0, 
containing 0.2 mg/ml bovine serum albumin (BSA), 150 mM potassium chloride. 
The mixture is prewarmed in a 37°C water bath and then 20 mM 5’-AMP is added to 
initiate the assay. Total volume of the reaction mixture is 100 ul. A 50 ul aliquot is 
removed at 60 minutes, frozen at -80°C, and stored at -20°C. Samples are analyzed 
by high performance liquid chromatography (HPLC) (Alliance 2695 Separations 
Module with 2998 Photodiode Array Detector, Waters, Millipore Corp.) using a 5 um 
C18 reversed phase column (Custom LC, Inc., Houston, TX) and running a gradient 
of mobile phase 20 mM ammonium phosphate, pH 5.1 with methanol added into the 
gradient. The gradient is designed as 0-4 minutes 0% methanol, 4-6 minutes 0-8% 
methanol, 6-8 minutes 8-20% methanol, 8-18 minutes 20% methanol.  
Analysis of adenine nucleotides in erythrocyte lysate 
Erythrocytes are isolated from whole blood by removing serum and washing 
3 times in ice-cold phosphate-buffered saline. Cells are lysed by freeze/thaw and 
then extracts are made by adding 3 volumes of ice-cold 70% methanol overnight. 
The supernatant is removed after centrifugation at 12,000 x g at 4°C for 10 minutes. 
Supernatant is evaporated to dryness and then resuspended in 200 ul mobile 
phase. The pellet is used to determine protein concentration. Nucleotides in the 
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extracts are separated by HPLC (Alliance 2695 Separations Module with 2998 
Photodiode Array Detector, Waters, Millipore Corp.) using a 5 um C18 reversed 
phase column (Sunfire, Waters, Millipore Corp.) and running a gradient with mobile 
phase of 150 mM KH2PO4 and 150 mM KCl, pH 6.0, with superimposed 15% 
acetonitrile (ACN). The gradient is programmed as 0-20 sec 0% ACN, 20 s – 21 min 
0-1.35% ACN, 24 min – 28 min 1.35-15% ACN, 29 min – 35 min 0% ACN. 
Nucleotides are quantified against standard curves of purchased standards (Sigma-
Aldrich, St. Louis, MO). 
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Chapter 3  
Introduction to the 5’-AMP - Induced Model of 
Deep Hypometabolism 
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Introduction 
The 5’-AMP – induced deep hypometabolism model was a fortuitous 
discovery in the laboratory, which primarily focuses on circadian rhythm research. A 
microarray comparing gene expression in liver samples of wild-type mice kept in 
12h:12h light/dark cycle or constant darkness found procolipase to be highly 
expressed during constant darkness (29). Procolipase is a coenzyme for pancreatic 
triglyceride lipase, and pancreatic lipase related proteins 1 and 2. These proteins 
catabolize dietary fats into fatty acids and are only expressed in pancreas and 
gastrointestinal tract, not in liver (30-32). Northern blot analysis of liver mRNA found 
strong circadian pattern to the procolipase expression in wild-type mice during 
constant darkness, but not during light-dark cycle. Wild-type mouse tissues 
expressed procolipase only in stomach and pancreas in normal light/dark cycle, but 
constant darkness caused expression in many other tissues (29).  
Through a series of several experiments tracking the procolipase expression, 
the observations suggested that procolipase expression is regulated by unknown 
circulatory factor(s) that control expression during either light/dark cycle or constant 
darkness. One of the approaches to identify the putative factor included high 
performance liquid chromatography (HPLC) analysis of blood extracts from mice at 
various time points in either light/dark cycle or constant darkness. From these 
studies, it was observed that one of the four reproducible peaks in all the samples 
had a strong circadian pattern in both the light/dark cycle and in constant darkness. 
In addition, it was observed that the peak area in samples from constant darkness 
was elevated compared to light/dark cycle, a feature consistent with the putative 
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factor. The peak had a maximum absorbance at 260 nm, which suggested it may be 
a nucleotide. The peak was confirmed to be 5’-AMP (29).  
Synthetic 5’-AMP was injected into mice kept in light/dark cycle to test 
whether it could induce expression of procolipase. Northern blot and RT-PCR 
analysis demonstrated induced expression of procolipase in all peripheral tissues 
sampled except for brain. Incidentally, the injection of 5’-AMP was found to induce a 
transient state of torpor in mice and was observed to decrease core body 
temperature (Tb) from 37°C to 26°C. (29).  
Injection of 5’-AMP induces a deep hypometabolic state which is moderated 
by ambient temperature 
Further studies showed that mice can enter a reversible deep hypometabolic 
state (DH) that can last several hours after treatment with 5’-AMP.  Initial 
investigations were performed to determine the physical parameters of the DH 
state. A temperature-controlled Comprehensive Lab Animal Monitoring System 
(CLAMS) metabolic chamber was used in our studies to measure the physiological 
effects of the 5’-AMP injection on mice.  Mice are housed in individual sealed cages 
with free access to food and water. Air in the cages is sampled to calculate the 
oxygen consumption, or VO2 in units of ml/kg/hr. Tb was measured simultaneously 
by implanting telemetry chips into the animals (33). 
We observed that placing the mice in a cold environment after 5’-AMP 
injection caused more reduction in Tb compared to Tb of mice in a 23°C 
environment. The effect of ambient temperature (Ta) on the reduction of Tb of mice 
21 
  
was investigated. The VO2 and Tb were monitored in mice injected with 0.5 mg/gw 
5’-AMP and placed in either a 23°C or 15°C metabolic chamber (Figure 2 a,b).  
Saline injected mice were used as controls. The saline-injected mice, at both 23°C 
or 15°C, maintained normal VO2 levels in the range of 4000 to 6500 ml/kg/h. In 
addition, they maintained Tb of approximately 37°C regardless of Ta. In contrast, 
between sampling points (~8 minutes) mice given 5’-AMP displayed a very steep 
and rapid decrease in VO2, to below 2000 ml/kg/h, and this occurred in both the 
23°C and the 15°C Ta groups. The first decrease in VO2 is referred to as the Phase 
I response. However, both Ta groups given 5’-AMP experienced only a small drop in 
Tb during the Phase I response. The saline injected animals in both groups did not 
experience a Phase I response, and they maintained euthermic Tb throughout the 
experiment. 
After the Phase I response, the effects of the two Tas diverged in the 5’-AMP 
injected groups. The decline in VO2 corresponded with a decrease in Tb. This was 
classified as the Phase II response, where the decline in Tb corresponds to the 
further decline in VO2. 
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Figure 2: Relationship between VO2, Tb and Ta following 5’-AMP injection. a and b, 
simultaneous measurement of Tb and VO2 of mice given saline or 5’-AMP (0.5 
mg/gw, indicated by arrow) in individual metabolic chambers at Ta of 23 and 15°C. 
Each mouse used in the study is represented by the same color trace for VO2 and 
Tb. Sampling time for both Tb and VO2 was about 8 min. The colors reflect VO2 and 
Tb of independent measurement of different animals given either saline or 5’-AMP. 
c, respiration rate of mice (n=4) with Tb ~16°C compared with 37°C. d, heart rate of 
mice (n=3) with Tb 16°C compared with 37°C. *, p<0.001, paired t test. Error bars, 
S.E.M. This research was originally published in The Journal of Biological 
Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, 
Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for 
Biochemistry and Molecular Biology.  
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The VO2 of mice in the 23°C environment reached a lowest point at 
approximately 1000 ml/kg/h, and their Tbs decreased to approximately 26 – 28°C. In 
contrast, the mice in the 15°C environment had a more dramatic decrease in VO2 
and Tb, to approximately 300 ml/kg/h and 16°C, respectively. These data show that 
colder Ta facilitates greater loss of body heat to the environment, allowing the mice 
in 15°C to reach a lower Tb and attain a much lower VO2.  
The breathing rate and heart rate of mice before and after 5’-AMP injection 
was also measured. Mice had a normal breathing rate of approximately 120 breaths 
per minute.  After injection of 0.5 mg/gw 5’-AMP, and cooling to a Tb of 16°C, the 
breathing rate decreased to approximately 10 breaths per minute. There was a 
similarly dramatic decrease in heart rate, from approximately 600 beats per minute 
to 50 beats per minute (Figure 2 c,d).  These physical measurements indicate that 
the mice were in an extremely low metabolic state and we regarded them to be in 
deep hypometabolism (DH). 
In summary, the Phase I response is rapid, occurring soon after injection of 
5’-AMP, and it is independent of Tb decrease. In contrast, the Phase II VO2 
response is more gradual, and apparently depends on the animal’s Tb, which in turn 
is regulated by Ta. Marked reductions in breathing rate and heart rate accompany 
the entry into DH. 
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Observations and description of mice in DH 
Distinct physical responses were observed in mice when they enter different 
degrees of hypometabolism. When the Tb reaches approximately 17°C, they are 
unable to right themselves when placed on their backs. However, they will respond 
to stimuli such as touch, but appear to be in a deep stupor. The mice do sometimes 
scratch, urinate, and roll side to side on their backs when in this state. Based on 
observations of the animals’ behavior, it was determined that mice enter the DH 
state when Tb reaches 17°C or below. The Tb generally stays one or two degrees 
above the Ta during the DH state. In our studies, the mice are maintained in the DH 
state at Ta of 15°C and a Tb of about 16°C. When Tb falls below 14°C, it can be fatal 
within a few hours. 
We observed that mice kept in a 15°C Ta will arouse spontaneously from the 
DH state. VO2 and Tb will both rise slowly at first. However, when the Tb reaches 
approximately 22°C, the mice will start shivering and the VO2 will rise rapidly. Within 
two hours their Tb will have returned to euthermia and normal behaviors such as 
grooming, eating and drinking and social behaviors are apparent. There was no 
difference in cognitive function of the mice after DH, as evaluated for both long-term 
and short-term effects by Morris Water maze testing (Figure 3). The animals 
showed no difference in escape latency. Also, there was no observed difference in 
lifespan of mice having undergone DH (33). The DH model works equally in male 
and female mice. 
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Figure 3: Morris Water Maze escape latency of mice before and after DH. n = 20, 
mice used were 8 weeks old and were trained to escaping from water maze for 6 
days before the experiment. The experiment was repeated 3 times and results are 
presented as +/- S.E.M. No significant difference between DH and before DH. 
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The dose of 5’-AMP induces the DH state but does not control its length  
 As shown in Figure 2b, the length of time in DH of individual mice is variable, 
generally lasting from 2-8 hours. The variability of length of time in DH caused us to 
question whether a larger dose of 5’-AMP could prolong the effect. To investigate 
the effect of different dosages of 5’-AMP on the length of time in DH, groups of mice 
with telemetry implants were injected with saline or a dose of 5’-AMP from 0.1 
mg/gw to 1 mg/gw and placed in a 15°C CLAMS metabolic chamber (Figure 4 
a,b,c,d).   
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Figure 4: DH as a function of 5’-AMP dosage. a-d, simultaneous measurement of 
Tb and VO2 of mice given different dosages of 5’-AMP and maintained at Ta of 15°C. 
The different colors in the graph reflect VO2 and Tb of different animals used in the 
study. This research was originally published in The Journal of Biological Chemistry. 
Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. 
Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for 
Biochemistry and Molecular Biology.  
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Mice given saline maintained approximately 37°C Tb under these conditions. 
The VO2 had normal fluctuations between 3500 – 4500 ml/kg/h, coinciding with 
periods of rest and activity. Both mice given 0.1 mg/gw 5’-AMP experienced the 
Phase I response, and a rapid decrease in VO2 from 4000 to 1500 ml/kg/h between 
the sampling points following 5’-AMP administration. One of the animals had a short 
Phase II response that corresponded with a slight decrease in Tb, but it did not enter 
DH. The other animal had an aborted Phase II response, and its Tb decreased a 
few degrees before returning to euthermia. In contrast, mice given 0.25 mg/gw 5’-
AMP both experienced the Phase I and Phase II responses, and stayed in DH 
several hours. Finally, mice given the highest dose, 1.0 mg/gw 5’-AMP, had Phase I 
and Phase II responses and stayed in DH for similar length as lower doses. 
  These studies revealed that the Phase I response was similar in all the 5’-
AMP treated mice, from the lowest to the highest dosages and is independent of Tb. 
For most mice to enter DH under the experimental condition used, a minimum dose 
of 0.25 mg/gw was required. Thus, our studies revealed that once the minimum 
dose of 5’-AMP is reached, giving a higher dose does not extend the time in DH. 
Therefore, it was concluded that the 5’-AMP injection of 0.25 mg/gw or more 
initiates DH, but does not control the length of time in that state. However, as shown 
previously in Figures 2a and 2b, for mice given the same dose of 5’-AMP, the Ta 
plays an important role in the length of time in DH. Of the mice given 0.5 mg/gw 5’-
AMP, the group in the 15°C environment stayed in the state for lengths ranging from 
2 to 8 hours, whereas the group in the 23°C environment only lasted less than 2 
hours. 
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Higher Ta causes more rapid recovery from DH 
The studies above showed that Ta is important in allowing the animal to cool, 
but it was important to test the effect of Ta on how quickly animals recover from DH. 
Mice were injected with 0.5 mg/gw 5’-AMP and placed in the 15°C metabolic 
chamber until their Tb reached about 16°C. Then, each group was placed in a 
different Ta, and the Tb was monitored until the animals had fully recovered to 
euthermia (Figure 5).  
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Figure 5: Arousal from DH and the rise in Tb of mice maintained at various Ta 
values. (n=4) This research was originally published in The Journal of Biological 
Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, 
Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for 
Biochemistry and Molecular Biology.  
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Mice kept in 15°C Ta stayed in DH the longest. As the Ta increased, the 
recovery from DH was correspondingly faster. These data demonstrate that the Ta 
is important in modulating the length of time it takes for arousal. However, the fact 
that once the minimum dose of 5’-AMP is reached, the dose of the 5’-AMP does not 
extend the length of time in DH, and the variability of length in DH, shows there are 
still factors that control arousal that remain unknown. This is supported by 
observations that giving the animals a second injection of 5’-AMP failed to prolong 
DH, and instead it led to increased mortality. In addition, further reduction of Tb to 
14°C or lower led to increased mortality.  
In summary, the Phase I response of a rapid and dramatic decline in VO2 
after 5’-AMP injection does not depend on the Ta or the Tb of the animals. However, 
the Phase II response, which is a more gradual decline in VO2, accompanied by a 
parallel decline in Tb, is controlled by the Ta.  During Phase II the Ta mediates the 
extent to which the animal will cool, as the body heat is transferred from a warm to a 
cooler state. However, the length of time until arousal varies for animals that have 
already entered DH and are maintained at the same Ta. Increased Ta enhanced the 
arousal and recovery rate from DH. 
Other species have successfully been induced into DH.  
 It was important to determine whether the effect of 5’-AMP would translate to 
larger mammals because it could possibly be used for therapeutic purposes in 
humans in the future. Also, it is easier to make some physiological measurements in 
larger mammals. 
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Induction of a rat into DH 
To test whether the effect of 5’-AMP will work in larger rodents, large male 
Sprague-Dawley rats, weighing 450 – 550g, were injected with 0.5 mg/gw 5’-AMP 
i.p., and cooled initially at 4°C Ta. After approximately 2 hours, the animals entered 
DH when the animal’s ability to right itself when laid on its side was no longer 
possible, with a corresponding Tb of 18 - 20°C. Transferred to 15°C Ta, the rats 
were able to maintain DH for 6 hours, after which they were gradually rewarmed to 
euthermia (Figure 6a). Thus, my studies showed that another species of rodent 
displayed a similar response to 5’-AMP – induced deep hypometabolism.  
Induction of a dog into DH 
To determine if the DH model works in another species of mammals, a 
beagle mix dog, weighing approximately 5 kg, was given 1.5 mg/g 5’-AMP via i.p. 
injection, and placed initially in a 4°C environment (Figure 6b). After 3 hours the 
animal entered the DH state, with a Tb of 22°C. It was transferred to an 18°C 
environment and it maintained a Tb of 21-22°C for 8 hours, after which it was 
gradually rewarmed to initiate arousal. After about 8 more hours it had returned to 
euthermia.  These findings demonstrated that a larger species, the dog, is able to 
enter 5’-AMP – induced deep hypometabolism. 
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Figure 6: Rat and dog induced into DH by injection with 5’-AMP and cooling. a, A 
representative profile of a 450 g male Sprague-Dawley rat was injected i.p. with 0.5 
mg/gw 5’-AMP and cooled in a 4°C Ta for 2 hours until the animal had entered DH 
with a Tb of ~18°C.  Then it was maintained in 15°C Ta with a Tb of 18-20°C for 6 
hours, and then gradually rewarmed to induce arousal. b, A representative profile of 
a ~5 kg beagle mixed breed dog injected i.p. with 1.5 mg/gw 5’-AMP and cooled in 
a 4°C Ta for 3 hours until the animal had entered DH with a Tb of ~22°C. Then it was 
transferred to 18°C Ta and its Tb remained at ~21-22°C for 8 hours, then the animal 
was gradually rewarmed to induce arousal, and it returned to euthermia within 8 
hours. This research was originally published in The Journal of Biological 
Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, 
Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for 
Biochemistry and Molecular Biology.  
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Induction of a pig into DH 
The effect of 5’-AMP – induced hypometabolism was also tested in pigs 
because the pig physiology is similar enough to that of humans to be valuable 
models for preclinical testing of drugs and surgical methods (34). A female Yucatan 
micro-mini pig weighing 27 kg was injected with 1.0 g/kg 5’-AMP, i.v., through a 
catheter inserted in the ear, and cooled with 10°C cooling blankets (Figure 7). The 
animal was maintained on 2% inhaled isoflurane anesthesia for approximately 20 
minutes before 5’-AMP injection, and then 1% isoflurane throughout the cooling 
process. Tb was measured by esophageal probe. The animal began to slightly 
shiver 100 minutes after injection, at which point Tb was 31°C. Anesthesia and 
cooling were stopped, but Tb continued to decrease despite the shivering, reaching 
a nadir of 29.6°C. Gradually the animal’s Tb rose and it returned to euthermia and 
normal behaviors after several hours. While the pig was able to be cooled after 
injection of 5’-AMP, anesthesia had to be used according to the institution animal 
welfare guidelines, so it was not possible to separate the effects of the anesthesia 
from the effects of the 5’-AMP.  
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Figure 7: Induction of a pig into DH. A 27 kg Yucatan micro-mini pig was 
administered 5’-AMP (1.0 mg/gw) intravenously over a 20 minute period (injection 
time indicated in blue shading) under 2% isoflurane anesthesia and placed between 
10°C cooling blankets. Cooling blankets and anesthesia were removed at 100 min 
at onset of shivering but Tb continued to decline to a nadir of 29.6°C. 
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In summary, 5’-AMP injection induces a hypometabolic state that is 
moderated by Ta.  There are two distinct phases of response after injection: a 
Phase I response characterized by a rapid, dramatic decrease in VO2 with not much 
decrease in Tb, and a Phase II response characterized by a gradual decline in VO2 
and Tb that is dependent on the Ta. Once the minimum dose is reached, the dose 
effect of 5’-AMP on length of time in DH and reduction of VO2 and Tb is not linear. In 
addition to mice, rats, a dog, and pigs were induced into DH state by 5’-AMP 
injection and cooling, and these data serve as proof of principle that the model 
works in larger mammalian species. Therefore, the mechanisms for inducing the DH 
state are shared in other species. Also, it suggests the model could potentially 
translate to humans for clinical applications such as therapeutic hypothermia. 
Understanding the fate of the injected 5’-AMP and the mechanisms that initiate the 
DH state is important for future applications. 
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Chapter 4 
Investigation of the role of 5’-AMP in the 
model of deep hypometabolism 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
44 
  
Since 5’-AMP can be converted to other molecules outside the cell, it was 
important to determine whether 5’-AMP itself was initiating the model. As shown in 
Figure 8, 5’-AMP can be converted to adenosine outside the cell in a reaction 
catalyzed by 5’-ectonucleotidase, also called CD73 (14, 16). In addition, it is well-
known that 5’-AMP can be phosphorylated to form ADP and ATP via adenylate 
kinase. The generation of 5’-AMP can come from catabolism of 3’,5’-cyclic 
adenosine monophosphate (cAMP) by phosphodiesterase (14, 16).   
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Figure 8: Adenosine metabolism and receptor signaling outside and inside the cell 
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Can different nucleotides initiate the DH model? 
Other mononucleotides were tested to investigate whether the hypometabolic 
effects were specific to 5’-AMP. Mice were injected with 0.5 mg/gw of either 5’-AMP, 
5’-cytidine monophosphate (5’-CMP), or 5’-guanosine monophosphate (5’-GMP) 
and placed in the metabolic chamber at 15°C (Figure 9). The mouse given 5’-AMP 
experienced the Phase I and Phase II responses, and remained in DH for almost 10 
hours. In contrast, neither the 5’-CMP nor the 5’-GMP injected animals had any 
significant change in VO2, and their Tb remained euthermic.  
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Figure 9: Comparison of VO2 levels in mice given 5’-AMP, 5’-CMP, or 5’-GMP. 
Each mouse was injected with 0.5 mg/gw of either nucleotide. This research was 
originally published in The Journal of Biological Chemistry. Daniels IS, Zhang J, 
O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem. 
2010; 285:20716-20723. © the American Society for Biochemistry and Molecular 
Biology. 
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To test the effect of the other adenine nucleotides, mice were given 0.5 
mg/gw ATP or cAMP, and response was compared to 5’-AMP injection. The 
animals did have a response, but it took much longer for the drug to take effect 
compared to the mice given 5’-AMP (Figures 10,11). The ATP-injected mouse 
Phase I response was slower than in the 5’-AMP-injected animal. The VO2 of the 
ATP-injected animal took longer to decline (Figure 10). Likewise, the cAMP-injected 
mouse had a kinetic rate similar to ATP in its Phase I response which is much 
slower than that displayed by 5’-AMP (Figure 11). The VO2 of the cAMP-injected 
animal also took longer to decline. In addition, other investigators have found that 
injection of 0.4 mg/gw ADP and ATP had similar effect to what we found with ATP 
and cAMP (35). These results suggest that conversion of cAMP, ADP and ATP to 
5’-AMP is required to have an effect.  
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Figure 10: Injection of 5’-ATP results in slower Phase I response than 5’-AMP. VO2 
and Tb were measured simultaneously in mice given 0.5 mg/gw 5’-AMP or 5’-ATP in 
individual cages in metabolic chamber at 15°C. Red arrow indicates injection time. 
a, VO2  b, Tb  c, high resolution plot of VO2 from part a. Note the difference in Phase 
I response. Time between sampling points is 3 min. 
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Figure 11: Injection of cAMP results in slower Phase I response than 5’-AMP         
a, VO2 was measured in mice treated with 5’-AMP or 3’,5’-cyclic AMP (cAMP), (0.5 
mg/gw). The cAMP treated mouse displays slower Phase I response 5’-AMP 
treated mouse. The cAMP treated mouse has an aborted Phase II response. The 
boxed area is shown in higher resolution in b, with 5 min sampling time. This 
research was originally published in The Journal of Biological Chemistry. Daniels IS, 
Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol 
Chem. 2010; 285:20716-20723. © the American Society for Biochemistry and 
Molecular Biology.  
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Adenosine was also tested. Mice given adenosine experienced a Phase I 
response, with the quick decrease in VO2, but did not have a Phase II response, 
and therefore did not enter DH (Figure 12). This transient effect of adenosine is not 
surprising as its half-life is less than 10 seconds in the serum (36). The result 
suggests adenosine is quickly metabolized before it can be phosphorylated into 
enough 5’-AMP to cause a Phase II response. 
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Figure 12: Injection of adenosine results in a Phase I response but an aborted 
Phase II response. VO2 was measured in mice treated with saline, 5’-AMP (0.5 
mg/gw) or adenosine (0.5 ml of 10 mg/ml) in 15°C Ta. This research was originally 
published in The Journal of Biological Chemistry. Daniels IS, Zhang J, O’Brien WG, 
Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem. 2010; 285:20716-
20723. © the American Society for Biochemistry and Molecular Biology. 
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Loss of CD73 did not block 5’-AMP induction of DH  
 The enzymes and receptors involved in adenylate metabolism and signaling 
are well studied, so they are useful tools in dissecting the fate of the injected 5’-
AMP. Outside the cell, 5’-AMP is dephosphorylated by the cell membrane anchored 
enzyme 5’-ectonucleotidase/CD73 to form adenosine (Figure 8). Thus, if conversion 
of 5’-AMP to adenosine outside the cell is required to initiate DH, then CD73 
deficient mice would be highly resistant to DH induced by 5’-AMP. The metabolic 
responses were compared between wild-type and CD73 deficient mice given 5’-
AMP and cooled. If conversion of 5’-AMP to adenosine outside the cell is essential 
to initiate DH, then the CD73 deficient mice would be more resistant to 5’-AMP 
induction of DH. The mice were injected with 0.5 mg/gw 5’-AMP and placed in a 
15°C metabolic chamber (Figure 13a). Interestingly, the CD73 deficient mice 
showed a similar response to the wild-type mice, with Phase I and Phase II 
responses, and stayed in DH for several hours. This result suggests that the 
dephosphorylation of 5’-AMP to adenosine by CD73 is not necessary to induce the 
DH state. 
Another experiment was performed to determine if the CD73 deficient mice 
would respond differently to a lower dose of 5’-AMP (Figure 13b). Mice lacking the 
enzyme CD73 would effectively be receiving a higher dose of 5’-AMP than the wild-
type mice because the 5’-AMP is not being converted to adenosine. The dose of 5’-
AMP, 0.125 mg/gw, was chosen since it is not completely effective in initiating DH in 
wild-type mice. Mice of each group (n = 12) were injected, and placed in a 4°C Ta 
for one hour, and then Tb was measured rectally.  Although a few of the wild-type 
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mice did cool, the majority did not reach DH. In contrast, the majority of the CD73 
deficient mice entered DH. The results from this experiment demonstrate that lack 
of the CD73 enzyme makes a lower dose of 5’-AMP more effective.  
Loss of adenosine receptors did not block 5’-AMP induction of DH 
 As part of analyzing the role of 5’-AMP conversion to adenosine outside the 
cell, it was important to determine whether adenosine receptor signaling is 
necessary to induce DH. Adenosine receptors have been shown to be involved in 
thermoregulation (37). The reaction of wild-type mice to injection of saline or 5’-AMP 
was compared to mice lacking either A1, A2A, A2B or A3 adenosine receptor (Figure 
13c).  Mice were given saline or 0.5 mg/gw 5’-AMP and then placed in a 4°C Ta for 
one hour.  
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Figure 13: Loss of adenosine receptors or 5’-ectonucleotidase deficiency does not 
block DH induced by 5’-AMP injection. a, the VO2 profiles of 
ectonucleotidase/CD73-deficient (n=2) and wild-type mice following 5’-AMP (0.5 
mg/gw) administration. b, individual Tb of ectonucleotidase/CD73-deficient and wild-
type mice (n=12) after 1h at 4°C Ta with injection of 0.125 mg/gw 5’-AMP. C, top, Tb 
time course of mice, (n=4) with the adenosine receptor genotype A1-/-, A2A-/-, A2B-/-, 
or A3-/- or wild-type were given 0.5 mg/g 5’-AMP after 1 h at 4°C Ta. bottom, Tb of 
mice of the same genotype given saline after 1 h at 4°C Ta. Error bars, S.E.M. This 
research was originally published in The Journal of Biological Chemistry. Daniels IS, 
Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol 
Chem. 2010; 285:20716-20723. © the American Society for Biochemistry and 
Molecular Biology. 
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Body temperature was measured rectally before injection, at 30 minutes and 
at one hour. All the wild-type and adenosine receptor deficient mice reacted 
similarly. The animals maintained body temperature after injection with saline. In 
contrast, the 5’-AMP injected animals all cooled to a body temperature of about 
17°C, and had entered DH by one hour post injection. The rate of cooling was 
similar between all groups. Additionally, the VO2 response of the adenosine 
receptor deficient mice was measured in the metabolic chamber (Figure 14). Wild-
type and adenosine receptor deficient mice were placed in the metabolic chamber 
at 15°C and treated with 0.5 mg/gw 5’-AMP. All the adenosine receptor deficient 
mice behaved similarly to the wild-type mice. There was a rapid decline in VO2 for 
the Phase I response, and then a slower decline in VO2 until the animals reached 
DH. They remained in that state for several hours before arousal and recovery to 
euthermia and normal VO2. These results demonstrate that no single adenosine 
receptor is required to initiate the effect. This is important because it suggests that 
adenosine signaling is not required for inducing the effect. 
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Figure 14: Wild-Type and adenosine receptor deficient mice have similar metabolic 
rate response to 5’-AMP injection and cooling at 15°C. Each line represents the VO2 
profile of one adenosine receptor genotype A1-/-, A2A-/-, A2B-/-, or A3-/- or wild-type 
mouse. Arrow indicates time of injection with 5’-AMP (0.5 mg/gw).  Phase 1 (PI) and 
Phase II (PII) responses are indicated. 
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Rapid decrease in heart rate is not required to initiate DH 
One of the striking physiological changes observed in animals injected with 
5’-AMP is a rapid and dramatic decrease in heart rate. The A1 adenosine receptor is 
known to mediate heart rate and vasodilation (37). Stimulating the A1 adenosine 
receptor decreases heart rate by decreasing conduction of electrical impulses and 
suppressing pacemaker cell function (38).  
To determine whether adenosine receptor control of heart rate plays a role in 
inducing DH, wild-type mice and mice deficient in A1, A2A, A2B or A3 adenosine 
receptor were injected with 5’-AMP, placed in a 22°C environment, and heart rate 
and Tb were monitored under isoflurane anesthesia for one hour (Figure 15). All the 
mice cooled similarly, reaching a body temperature of approximately 23°C. The 
heart rate of the wild-type and the A2A, A2B and A3 receptor deficient mice 
decreased rapidly, reaching approximately 200 beats per minute within 2 minutes of 
injection. In contrast, the heart rate of the A1 receptor deficient mice did not show 
this rapid decrease. This result corresponds to the function of the A1 adenosine 
receptor in mediating heart rate. Even though the A1 receptor deficient mouse did 
not have the sharp decrease in heart rate after the 5’-AMP injection, it still cooled 
similarly to the wild-type mouse and the other adenosine receptor deficient mice. 
This shows that the adenosine receptor signaling influence on heart rate is not 
required to induce the model, and also that the rapid decrease in heart rate itself is 
an effect, and not a cause.  
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Figure 15: Rapid decrease in heart rate is not essential to induce DH. One each of 
wild-type, A1, A2A, A2B, and A3 adenosine receptor deficient mice were injected 
with 0.5 mg/gw 5’-AMP at 22°C Ta. Heart rate and Tb were measured 
simultaneously. Data from Dr. Zhenyin Tao, unpublished observation. 
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In summary, the results from the CD73 deficient mice experiments show that 
dephosphorylation of 5’-AMP to adenosine outside the cell is not required for the 
initiation of DH. The loss of adenosine receptors did not affect the ability of 5’-AMP 
to initiate the hypometabolic response.  Adenosine can initiate the Phase I response 
but its effect is rather short lived. The loss of A1 adenosine receptor did not block 5’-
AMP - induced DH but it blocked the rapid bradycardia effects of adenosine. The 
kinetics of ATP and cAMP are much slower than that initiated by 5’-AMP in the 
induction of DH. Other nucleotides including 5’-CMP and 5’-GMP are not effective. 
The results suggested that 5’-AMP itself may be initiating the DH model. To gain 
more insight into the mechanisms involved, we measured metabolic and 
biochemical parameters. 
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Chapter 5 
The erythrocyte is the site of initiation for the 
5’-AMP – induced model of deep 
hypometabolism  
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The results from the experiments with the CD73 deficient and adenosine 
receptor deficient mice demonstrated that dephosphorylation of 5’-AMP to 
adenosine and adenosine receptors signaling was not essential to induce the deep 
hypometabolism model. Further biochemical analysis was needed to determine the 
fate of the 5’-AMP. We undertook studies to determine the metabolic and 
biochemical changes that occur after 5’-AMP injection. 
The serum of mice in DH contains elevated purine catabolic products 
A metabolomics study gave a detailed overview of the metabolic status of mice in 
DH. Serum was analyzed from mice before injection, 3 hours into DH, at the arousal 
stage, and early in their recovery. Analysis incorporated liquid and gas 
chromatography and mass spectrometry to determine the metabolites in the 
samples and calculate relative fold difference from the euthermic state, and was 
carried out by a commercial service company (Metabolon, Research Triangle Park, 
NC). Compared to the euthermic level, the 5’-AMP level in the serum of mice in 
deep hypometabolism and at the arousal stage was increased only by 1.2 - 1.5 fold. 
This suggests that much of the injected 5’-AMP had already been catabolized by 
the time the mice were in DH. Further evidence of the 5’-AMP catabolism came 
from the results that showed levels of several of the purine catabolites, such as 
inosine, xanthine, xanthosine, hypoxanthine, urate, and allantoin had greatly 
increased by DH (Table 1). Analysis of serum metabolites of mice in early recovery 
showed that the purine catabolites had generally returned to the levels seen in mice 
before injection, with the exception of allantoin, the final product in the purine 
catabolic pathway in mice. During the deep hypometabolic state, there was about a 
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2 fold increase in ADP levels, whereas adenosine levels were lower than euthermic 
state. The metabolite measurements suggest that the 5’-AMP is being primarily 
catabolized by the AMP deaminase rather than through the adenosine deaminase 
pathway (Table 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
72 
  
Table 1 Metabolomics analysis shows significant alternation in relative levels of 
purine intermediates in serum. This research was originally published in The 
Journal of Biological Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, 
Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. © the 
American Society for Biochemistry and Molecular Biology. 
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Serum and erythrocytes of mice in DH have elevated 2,3-bisphosphoglycerate 
Another interesting finding from the metabolomics analysis is that there was 
a large increase in 2,3-bisphosphoglycerate (2,3-BPG) in the mice in DH compared 
to mice preinjection (Table 2). 2,3-BPG is synthesized from 1,3-BPG in the 
erythrocyte and  in the placenta, catalyzed by the enzyme bisphosphoglycerate 
mutase. This enzyme is only found in erythrocytes and placenta, so the increase in 
2,3-BPG during DH suggested that the erythrocyte is implicated in the model. To 
further investigate the timing of the increase in 2,3-BPG after 5’-AMP injection, an 
experiment was performed in which the 2,3-BPG levels were measured in 
erythrocyte samples isolated from blood taken from mice over a time course before 
and after 5’-AMP injection (Figure 16). The 2,3-BPG levels had significantly 
increased by the first sampling 10 minutes after injection, and continued to rise 
during the following 30 minutes. However, by arousal state, the levels of 2,3-BPG 
had returned to preinjection levels. These results suggested the possibility that the 
erythrocyte is involved in the underlying mechanism of deep hypometabolism 
induced by 5’-AMP.  
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Table 2: Metabolomics analysis shows 3.57-fold increase in 2,3-BPG in serum of 
mice in DH compared to euthermia 
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Figure 16: 2,3-BPG levels rise in the erythrocytes (RBC) of mice after 5’-AMP 
injection and then return to pretreatment levels by arousal from DH. n = 6, error 
bars indicate +/- S.E.M, p< 0.05. This research was originally published in The 
Journal of Biological Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, 
Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. © the 
American Society for Biochemistry and Molecular Biology. 
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After 14C-AMP injection in vivo, 14C signal is highest in blood, heart, lung and 
kidney 
 A literature search revealed a study in which mice were injected with 11C-
AMP and then the 11C signal was traced to primarily lungs, blood and heart. The 
authors did not perfuse the tissues, so some of the signals in lung and heart may 
have come from blood in these organs (39). The authors observed that very little of 
the 11C signal crossed the blood brain barrier. In the study, they further 
demonstrated that the 11C-AMP was rapidly taken up by erythrocytes and was first 
converted to ADP and then ATP. In addition, they showed that uptake of 11C-AMP 
by the blood, unlike in the lungs, was not inhibited by dipyridamole, an inhibitor of 
adenosine uptake by the cells. The authors also observed that kidney and bladder 
were critical organs for the 11C signal, indicating that the 11C-AMP is metabolized 
and cleared through the urinary system. To replicate these studies, blood and 
perfused tissues were collected from a female C57Bl/6 mouse 5 minutes after 
injection with 14C-AMP (Figure 17).  Samples were homogenized and then 
scintillation counts of 14C signal were measured, normalized to protein 
concentration. Similar to the published results, the highest 14C signal was in the 
blood, heart, and lung, and in addition the kidney had high counts. Consistent with 
published observations, there was very little 14C signal in the brain, which suggests 
that the injected 5’-AMP did not cross the blood-brain barrier. The observation that 
blood had high 14C signal corresponded with the results showing elevated 2,3-BPG 
levels in the mice given 5’-AMP, suggesting that the erythrocyte could be an 
important target of the metabolite.  
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Figure 17: 14C signal is highest in blood, heart, lung and kidney after 14C-AMP 
injection in vivo. Blood and tissues were collected from a wild-type C57Bl/6 female 
mouse 5 minutes post-injection with 14C-AMP.  
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Glycolysis is slowed in the erythrocytes of mice in DH 
The metabolite 2,3-BPG is a product of the glycolytic shunt in the 
erythrocyte. The glycolytic shunt is favored when glycolysis is slowed (16, 40). A 
slower rate of glycolysis would cause an increase in cellular glucose, and a 
decrease in lactate. Therefore, we measured glucose and lactate levels in the 
isolated erythrocytes of mice before 5’-AMP treatment and also during DH (Figure 
18). The glucose levels of mice in DH were 3 times higher than pre-injection, 
whereas the lactate levels were 2 times lower. These results are consistent with a 
slowed glycolysis in the erythrocytes of the mice injected with 5’-AMP and this is 
related to the increase in 2,3-BPG.  Together, these studies implicate a role for the 
erythrocytes in the 5’-AMP mediated hypometabolism. 
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Figure 18: Glucose levels increase and lactate levels decrease in the erythrocytes 
of mice treated with 5’-AMP. n = 4, error bars indicate +/- S.E.M, p< 0.01. This 
research was originally published in The Journal of Biological Chemistry. Daniels IS, 
Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol 
Chem. 2010; 285:20716-20723. © the American Society for Biochemistry and 
Molecular Biology.  
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5’-AMP is taken up and metabolized in erythrocytes, favoring formation of 
ADP  
Erythrocytes are unique in that they lack nuclei and mitochondria, therefore 
they rely primarily on glycolysis to make ATP and they are unable to perform de 
novo nucleotide synthesis (41, 42). Mature erythrocytes lack the enzyme 
adenylosuccinate synthetase, which catalyzes conversion of inosine 
monophosphate (IMP) to adenylosuccinate. Therefore, they are unable to complete 
the purine nucleotide cycle to convert IMP to AMP. They must use salvage 
pathways to recycle nucleotides (14, 41). Previous experiments had shown that 
extracellular adenosine is not required to initiate the model, but implicate that 5’-
AMP itself was entering the erythrocyte. Currently there is no described transporter 
for 5’-AMP, but it has been reported that adenosine cyclic 3’,5’-monophosphate 
(cAMP)  and guanosine 3’,5’-cyclic monophosphate (cGMP) can enter erythrocytes 
(43, 44). Adenosine can rapidly enter the erythrocyte (45). Previous studies have 
demonstrated uptake of 14C-labeled adenosine into erythrocytes, and analyzed the 
14C-labeled products inside the erythrocyte lysate (45). Experiments were 
performed to determine if 14C-AMP can directly enter the erythrocyte (Figure 19).  
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Figure 19: Uptake of 14C labeled adenosine and 5’-AMP into erythrocytes isolated 
from wild-type mice, compared with known 14C-labeled purine standards. 
Erythrocyte lysates were separated by thin layer chromatography. This research 
was originally published in The Journal of Biological Chemistry. Daniels IS, Zhang J, 
O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem. 
2010; 285:20716-20723. © the American Society for Biochemistry and Molecular 
Biology. 
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First, the experiment was performed with 14C-adenosine to determine if the 
published results could be replicated. Isolated wild-type mouse erythrocytes were 
incubated with 14C-adenosine over a time course up to one hour, and then washed 
and lysed. The contents of the cell lysate were separated by thin layer 
chromatography (TLC) and the radiolabeled contents were visible on an 
autoradiogram of the TLC plate. Radiolabeled standards were run on the TLC plate 
to identify the products. We observed that adenosine was taken up into the cells 
rapidly, consistent with the published literature.  The 14C-adenosine taken up into 
the erythrocytes mainly formed 14C-AMP and 14C–ADP. This suggests that inside 
the cell, adenosine is being phosphorylated by adenosine kinase to form AMP and 
then phosphorylated by adenylate kinase into ADP. When the experiment was 
performed with 14C-AMP, rapid uptake was also observed. Product formation 
favored 14C-ADP, and there was no detectable formation of ATP. These 
observations could be explained by the adenylate equilibrium AMP + ATP  2 
ADP. If AMP levels rise inside the cell, the adenylate equilibrium will balance this 
rise by converting part of the 5’-AMP into ADP by utilizing intracellular ATP. Similar 
outcome was observed when erythrocytes from CD73 deficient mice were used. 
Analysis of the lysate contents showed uptake of 14C-AMP, and formation of 
ADP, with trace levels of inosine and adenosine. The presence of inosine and 
adenosine suggests that the AMP inside the cell could be catabolized by AMP 
deaminase to IMP, and then IMP could be dephosphorylated to inosine by cytosolic 
nucleotidase. An alternative path could be AMP  adenosine by cytosolic 
nucleotidase, and then adenosine  inosine by adenosine deaminase. Uptake by 
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the CD73 deficient erythrocytes suggested the 14C-AMP is likely entering the cell 
directly. In addition, previous studies showed that uptake of 5’-AMP by erythrocytes 
is not blocked by dipyridamole, unlike in the peripheral tissues (39). 
ADP rises, ATP declines, and 5’-AMP is metabolized in blood of mice in DH  
It was evident that 5’-AMP is taken up into the erythrocyte in the in vitro 14C-
AMP uptake experiments. However, to determine the fate of the 5’-AMP in vivo, an 
analysis of the purine nucleotides in blood was performed using HPLC. Blood 
extracts were analyzed from mice in euthermia, deep hypometabolism, arousal 
stage, and mice given a second injection of 5’-AMP during the deep hypometabolic 
state (Figure 20).  
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Figure 20: Representative HPLC chromatograms of purine products in wild-type 
mouse blood extracts of mice in a) euthermia, b) during DH c) spontaneous arousal, 
d) a mouse given a second injection of 5’-AMP (0.5 mg/gw) and sacrificed 2 hours 
later. This research was originally published in The Journal of Biological Chemistry. 
Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. 
Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for 
Biochemistry and Molecular Biology. 
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The extract from the deep hypometabolic state had increased ADP and AMP, and 
decreased ATP levels. This suggested influx of AMP caused a change in the 
adenylate equilibrium, forcing an increase in the ADP which caused a decrease in 
the ATP level. Also, there was evidence of metabolism of AMP as shown by the 
appearance of inosine and uric acid, products of purine metabolism. The blood 
extract from mice given a second injection of 5’-AMP after entering DH showed a 
large increase in the ADP level as well as the inosine and uric acid. Due to the 
adenylate equilibrium, AMP + ATP  2 ADP, the ATP level decreased 
dramatically. This suggests that there was more metabolism of the 5’-AMP, shifting 
the adenylate equilibrium to very low ATP levels. This result corresponds with the 
observation that a second injection of 5’-AMP while the animal is already in DH is  
 
Erythrocytes of mice given 5’-AMP have increased levels of deoxyhemoglobin 
 
  
 
 
 
a) Euthermic c) Spontaneous Arousal 
b) D ep Hypom tabolism d) 5’-AMP during DH 
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Experiments had shown that the erythrocytes of mice in DH had elevated 
2,3-BPG, which is known as an allosteric regulator of the ability of hemoglobin to 
bind oxygen (14).  Thus, high levels of 2,3-BPG would cause less oxygen to be 
bound to hemoglobin. When analyzed by a spectrophotometer, deoxyhemoglobin 
has signature peak absorbance at 760 nm, whereas oxyhemoglobin has weaker 
absorbance at 660 nm. Blood samples were taken 10 minutes post-injection of 0.5 
mg/gw 5’-AMP or saline. Spectral analysis of samples from the treated mice 
showed evidence of deoxyhemoglobin at 760 nm. In contrast, samples from the 
untreated group had weaker absorbance at 660 nm, showing presence of more 
oxyhemoglobin (Figure 21). The results confirm that erythrocytes of mice treated 
with 5’-AMP are less able to transport oxygen to tissues.  
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Figure 21: Spectral absorbance of whole blood from mice treated with 5’-AMP 
(dashed lines) or untreated (solid lines). Blood samples were taken 10 minutes after 
5’-AMP injection, i.p., (0.5 mg/gw), n = 2. This research was originally published in 
The Journal of Biological Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki 
T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. © 
the American Society for Biochemistry and Molecular Biology. 
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Summary of results 
 The metabolomics study showed an increase in 2,3-BPG in the serum of 
mice in DH. Erythrocytes isolated from mice treated with 5’-AMP also had increased 
2,3-BPG levels, as well as increased glucose and decreased lactate levels, 
indicating slower rate of glycolysis. Hemoglobin oxygen affinity is inhibited by 2,3-
BPG, and spectrophotometry analysis demonstrated that the injection of 5’-AMP 
resulted in increased levels of deoxyhemoglobin levels. Consistent with previous 
studies, our tracing of 14C signal in tissues after injection of radiolabeled 5’-AMP 
demonstrated highest localization in blood and in vascular tissues such as heart, 
lung and kidney. Furthermore, in vitro treatment of isolated erythrocytes with 14C-
AMP showed evidence of direct uptake and metabolism of 5’-AMP.   HPLC analysis 
of the purine products in blood extracts of mice in DH demonstrated that 
metabolism of 5’-AMP occurs in the blood, and there is a shift in the adenylate 
equilibrium favoring formation of ADP and decrease in ATP levels. Taken together, 
these results indicate uptake of 5’-AMP into the erythrocyte is involved in the 
initiation of the DH state. 
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Chapter 6 
AMP Deaminase in the erythrocyte plays an 
important role in control of the DH model 
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AMP deaminase is the major pathway for 5’-AMP catabolism inside the cell. 
AMP deaminase catalyzes deamination of 5’-AMP to 5’-inosine monophosphate (5’-
IMP), requiring a H2O molecule and releasing NH4+ (14) (Figure 22). IMP can be 
converted to inosine via cytosolic nucleotidase. Inosine then is converted to 
hypoxanthine, then xanthine, and then urate. The final product in humans is urate 
but many species including mice have urate oxidase which creates the final product 
allantoin (16).  
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Figure 22: Adenine nucleotide metabolism pathways inside and outside the 
cell 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99 
  
 
 
 
 
 
 
 
 
 
 
 
 
100 
  
Humans have four isozymes of AMPD that are encoded on different genes. 
AMPD1, also called myodenylate deaminase, is the main type in skeletal muscle. 
AMPD2, also called L form, was first isolated from liver, and AMPD3, also called E 
form, is highly expressed in heart tissue. In humans and other species, many 
tissues express multiple AMPD isozymes in varying amounts. AMPD3 as well as 
other AMPD isozymes are expressed in heart and slow-twitch skeletal muscle, but 
interestingly, erythrocytes only have AMPD3 (46, 47). In humans, AMPD3 has two 
splice variants: E1 and E2, and the E1 variant is the only type found in erythrocytes. 
AMPD3 E2 type is found in granulocytes, AMPD2 is found in mononuclear cells, 
platelets and T-cells, whereas both AMPD3 E1 and AMPD2 are found in B-cells 
(48-50).  
In the literature there are a few described cases of genetic mutation causing 
a complete lack of AMPD3 in humans. The deficiency was found to be clinically 
asymptomatic, although there is an increase of steady-state ATP levels to 150% in 
the affected cells (51). Unlike human AMPD3, murine AMPD3 just has one form; it 
has no splice variants. It is also called heart AMPD3, because the cDNA was first 
isolated and cloned from mouse heart, where it is highly expressed (47).   
 In most mammalian species, erythrocytes lack an enzyme that allows IMP to 
be converted to 5’-AMP. The conversion of 5’-AMP to IMP is irreversible because 
the cells lack the enzyme adenylosuccinyl synthetase and thus lack the ability to 
convert IMP back to AMP (41, 42).  
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 Studying mice deficient in AMPD3 in the erythrocyte could help elucidate the 
role of AMPD and the erythrocyte in the DH model. Thus, we undertook the 
generation of mice deficient in AMPD3. Embryonic stem cells with C57Bl/6 
background were purchased from Knockout Mouse Project Repository, University of 
California, Davis, CA. The vector used the “knockout-first” technology to insert the 
cassette in the intron 1 before the essential exon 2 to create a missense mutation 
that results in a non-functional mRNA transcript. The cells were injected into the 
blastocysts of pseudopregnant C57Bl/6 females at the core facility at Institute for 
Molecular Medicine, Houston, TX, and chimeras were generated. Chimeras were 
mated with C57Bl/6 mice to generate heterozygous knockouts, and then 
homozygous knockouts were generated.  
 
AMPD activity is not detectable in erythrocytes and is reduced in heart of 
AMPD3 deficient mice 
 To confirm that the gene knockout was successful, it was necessary to 
measure the AMPD enzyme activity in the tissues of the mice, including the 
erythrocytes (Figure 23).  
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Figure 23: AMPD activity is not detectable in the erythrocytes (rbc) and is reduced 
in the heart of AMPD3 deficient mice. erythrocytes (rbc)  n = 15 wild-type and n = 7 
AMPD3 deficient. serum n = 10 wild-type and n = 5 AMPD3 deficient. heart n = 8 
wild-type and 8 AMPD3 deficient. All other tissues n = 3. Error bars = +/- S.E.M 
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AMPD activity was measured by quantifying the IMP formed in a reaction of 
tissue lysate using 5’-AMP as previously described (52). In parallel, wild-type mouse 
tissues were measured as controls. In most tissues, AMPD3 deficient mice had 
AMPD activity comparable to wild-type. However, there was much lower AMPD 
activity in heart, as compared to wild-type, and the AMPD activity in the erythrocyte 
lysate was not detectable. Other isozymes of AMPD are expressed in the heart, so 
it would be expected to have some AMPD activity. The erythrocyte lysate of 
heterozygous mice had less AMPD activity than wild-type, but more than the 
deficient mice (Figure 24). The results demonstrate that the AMPD3 enzyme is not 
active in the AMPD3 deficient mice. 
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Figure 24: AMPD activity in erythrocyte lysate of wild-type, heterozygous and 
homozygous AMPD3 deficient mice. n = 2-3 mice per group, error bars = +/= S.E.M 
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ATP and ADP but not 5’-AMP levels are elevated in the erythrocytes of AMPD3 
deficient mice 
 Next, we investigated whether the loss of AMPD3 will result in elevated 
levels of 5’-AMP in the erythrocyte of AMPD3 deficient mice. HPLC analysis was 
performed to quantify the levels of ATP, ADP and 5’-AMP in methanol extracts of 
erythrocyte lysate (Figure 25).  
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Figure 25: Erythrocyte lysates of AMPD3 deficient mice have 3-fold higher ATP and 
ADP levels and similar AMP levels to wild-type mice. Nucleotides from methanol 
extracts of erythrocyte lysates were separated on HPLC and quantified by 
calibration curves of standards. n = 4, error bars = +/- S.E.M. Student t-test p 
values: ATP, p = 0.02. ADP, p = 0.04. 
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Adenine nucleotide amounts were quantified against calibration curves for 
ATP, ADP and 5’-AMP, and normalized to the protein concentration in each lysate 
sample. While the AMP levels were similar to wild-type, AMPD3 deficient 
erythrocytes had a 3-fold increase in both ATP and ADP levels.  These results are 
contrary to our prediction but are consistent with observation in humans deficient in 
AMPD3. The affected cells in humans with AMPD3 deficiency have 150% of normal 
ATP levels, although ADP and 5’-AMP levels are not mentioned (53). A possible 
explanation for the observation is that the loss of AMPD3 blocks the breakdown of 
5’-AMP to IMP. The only catabolic exit for 5’-AMP is via adenosine to inosine by 
adenosine deaminase (ADA). However, the Km of ADA is much higher than that of 
adenosine kinase, which converts adenosine to AMP. Consequently, the adenine 
nucleotide pool is much larger, and to balance the adenylate equilibrium, both ATP 
and ADP have to rise, consequently 5’-AMP levels remain low. 
AMPD3 deficient mice have similar metabolic rate and glucose utilization to 
wild-type mice 
 We then investigated whether the change in the adenylate levels in the 
erythrocyte will affect metabolic rate of the animals. The calculation for VO2, 
mg/kg/h, involves the weight of the animal. We have consistently observed that a  
lower weight animal tends to have a higher metabolic rate. To overcome this 
possible artifact, we chose similar weight mice to compare VO2 between animals. 
Wild-type, heterozygous and homozygous AMPD3 deficient male mice of similar 
weight were measured in the CLAMS metabolic chamber for 7 days with free 
access to food and water, and under 22°C Ta.  Our analysis revealed that there was 
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no significant difference in VO2 for the different genotypes. Average VO2 of wild-
types was 3530 ml/kg/hr, heterozygous mice was 3412 ml/kg/hr and homozygous 
mice was 3473 ml/kg/hr (Figure 26).  
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Figure 26: Metabolic rates (VO2) are similar in similar weight male wild-type, 
heterozygous and homozygous AMPD3 deficient mice. wild-type n = 5, 
heterozygous n = 4, homozygous n = 7. Error bars = +/- S.E.M. 
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It is well known that ATP/AMP ratio acts as allosteric regulator for key 
enzymes of glycolysis. Elevated AMP levels signal a need for ATP production, and 
activate phosphofructokinase 1, a key enzyme in the glycolytic pathway (16). 
Potentially the change in adenine nucleotide ratio could affect glycolytic rate and 
therefore blood glucose levels. Thus, we undertook to measure fasting blood 
glucose in wild-type and AMPD3 deficient mice (Figure 27).  
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Figure 27: AMPD3 deficient mice have similar fasting blood glucose to wild-type 
and heterozygous mice. wild-type n = 14, heterozygous n = 9, homozygous n = 16. 
Error bars = +/- S.E.M. 
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Animals were fasted overnight for 12 hours and then blood glucose was 
measured the next morning. In a parallel experiment animals were fasted for 12 
hours during the day and blood glucose was measured at night. In both 
experiments, the AMPD3 deficient mice had slightly higher glucose levels, but it was 
not statistically significant and is within the normal range of fasting blood glucose. 
The average fasting blood glucose of the wild-type mice was 69 mg/dl, 
heterozygous mice was 70 mg/dl, and homozygous mice was 73 mg/dl. These 
studies indicate that glucose utilization was within normal range in AMPD3 deficient 
mice. 
AMPD3 deficient mice have more dramatic response to injection of 5’-AMP  
Next we investigated how AMPD3 deficient mice would respond to injection 
of exogenous 5’-AMP. We predicted that 5’-AMP would be catabolized more slowly 
in the erythrocytes lacking AMPD3 and they would be more sensitive to 5’-AMP - 
induced DH. Wild-type and AMPD3 deficient mice were injected with a dose of 5’-
AMP and then placed in a 15°C metabolic chamber with free access to food and 
water. They were monitored and VO2 was recorded until all the animals recovered 
from DH. First, a series of dose titration experiments were performed to determine 
the minimum 5’-AMP dose at which wild-type and AMPD3 deficient mice responded 
differently. That dose was 0.15 mg/gw 5’-AMP when using 15°C Ta. All the animals 
experienced the immediate Phase I response after the 5’-AMP injection. The data 
was analyzed based on length of time in the Phase II response. Since Tb decreases 
when the VO2 drops below 1500 ml/kg/h, the average time in Phase II state was 
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used to determine the Phase II response. On average, the AMPD3 deficient mice 
stayed in the Phase II response much longer than the wild-type mice (Figure 28).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
119 
  
Figure 28: Male and female AMPD3 deficient mice stay in Phase II response much 
longer than wild-type mice when injected with a lower dose of 5’-AMP (0.15 mg/gw) 
and maintained in 15°C Ta. Time in Phase II response is represented as minutes 
the VO2 is below 1500 ml/kg/h. females n = 12 each group, males n = 3. Error bars 
= +/- S.E.M. 
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The AMPD3 deficient females stayed in Phase II 81 minutes, compared to 
wild-type females with an average of 21 minutes. Similarly the AMPD3 deficient 
males stayed in Phase II for 216 minutes, compared to wild-type male mice which 
stayed in Phase II for 42 minutes. Thus, the AMPD3 deficient mice stay in Phase II 
much longer than the wild-type animals, indicating that they were more sensitive to 
a lower dose of 5’-AMP.  
AMPD3 deficient mice have lower core body temperature than wild-type mice 
 Next, we examined whether the core body temperature of wild-type and 
AMPD3 deficient mice was normal. Since physical activity or stress can directly 
impact Tb, we decided to use the telemetry approach for this measurement.  
Telemetry-chip implanted animals were placed in a 22°C metabolic chamber with 
free access to food and water, and core body temperature was measured over a 
period of 7 days (Figure 29).   
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Figure 29: AMPD3 deficient mice have lower Tb than wild-type mice. Tb of 
telemetry-implanted mice was measured for 7 days in a 22°C Ta. Error bars = +/- 
S.E.M., n= 7 each group. 
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To analyze the data, the average of the highest and lowest ten percent 
recordings was calculated. The average top ten percent readings for the AMPD3 
deficient mice was 37.0°C, almost a full degree lower than the wild type mice 
average of 37.8°C. The average bottom ten percent readings for the AMPD3 
deficient mice was 32.5°C, almost 2 degrees lower than the wild type mice average 
of 34.3°C. It is evident from the graph of the Tb of the wild-type and AMPD3 
deficient mice that both genotypes have the normal fluctuations in body temperature 
throughout the day that correspond to rest and activity. However, in the AMPD3 
deficient mice the high and low body temperatures are shifted lower in comparison 
to wild-type. 
AMPD3 deficient mice have difficulty maintaining normal body temperature 
under moderate metabolic stress 
 To further explore the AMPD3 deficient mouse phenotype of lower core body 
temperature, it was important to determine how the animals would react to 
metabolic stress such as a slight decrease in ambient temperature. Wild-type and 
AMPD3 deficient mice were placed in the metabolic chamber at 22°C, with free 
access to food and water for 5 days. Then the ambient temperature in the chamber 
was decreased to 18°C, and the animals were monitored for two more days. Both 
groups of mice showed an increase in VO2 when the ambient temperature 
decreased. The wild-type mice maintained their Tb, that accompanied the increase 
in VO
 2. However, some AMPD3 deficient mice had a decline in Tb after the ambient 
temperature decreased, even though their VO2 had increased (Figure 30). Also, in a 
few of the mice, it was observed that some AMPD3 deficient mice would 
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spontaneously enter daily torpor even during the 22°C period (Figure 31).  These 
observations indicate the AMPD3 deficient mice are impaired in their ability to 
maintain core body temperature. It is important to note that under extreme 
metabolic stress such as fasting or Ta of 15°C or lower, both wild-type and AMPD3 
deficient mice will undergo torpor. 
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Figure 30: Some AMPD3 deficient mice have reduced ability to maintain Tb when 
Ta is reduced from 22°C to 18°C, despite increase in VO2. Representative plot of 
VO2 and Tb from one wild-type and one AMPD3 deficient mouse. Note that random 
outliers in Tb measurement are caused by the positioning of the mouse and 
telemetry chip to the sensor. 
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Figure 31: Daily torpor of AMPD3 deficient mice at 22°C Ta. Representative plot of 
VO2 and Tb of an AMPD3 deficent mouse entering torpor in 22°C and 18°C Ta, over 
a period of 6 days with free access to food and water. Note that random outliers in 
Tb measurement are caused by the positioning of the mouse and telemetry chip to 
the sensor. 
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Summary of Results 
 In summary, AMPD3 deficient mice have similar VO2 and glucose utilization 
to wild-type mice. They display a more dramatic response to lower dose 5’-AMP 
injection than wild-type mice, suggesting that AMPD3 activity, specifically in the 
erythrocyte, is important to the control of the 5’-AMP – induced model of DH. The 
increased ATP and ADP in the erythrocytes, their lower Tb phenotype, and the 
difficulty some of the mice have maintaining Tb during moderate metabolic stress 
suggest altered energy homeostasis that must be further investigated. 
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Chapter 7 
Discussion and Future Directions 
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Expression level of most genes in mouse liver are unaltered during DH 
The physiological effects of the 5’-AMP injection occur so rapidly 
(immediately) that the laboratory’s initial studies on the mechanism focused on 
biochemical changes rather than gene expression. However, it was important to 
determine what changes in gene expression occur after 5’-AMP treatment. A 
microarray study compared the expression of genes in the liver, a highly metabolic 
organ, of mice in DH, at arousal, and recovered from DH, compared to control 
untreated mice. More than 99% of gene expression in the liver was unchanged in 
DH, compared to untreated animals. In contrast, the arousal stage had much more 
change in gene expression, with about 200 genes differentially expressed 
compared to only about 40 genes in the DH state. These results showed that 
patterns of gene expression are mostly held constant during DH. The expression of 
circadian genes is stalled as well. Analysis of expression 24 and 48 hours post 
recovery indicated that the circadian clock takes approximately 24 hours to reset 
after DH. The cold Tb likely causes the stalling of most gene expression changes  in 
DH (54). 
Model for initiation of 5’-AMP - induced deep hypometabolism 
Adenosine receptor signaling is known to be involved in thermoregulation 
and heart rate, both of which undergo dramatic changes in the DH model (37). 
Since 5’-AMP can be dephosphorylated to adenosine, the initial focus on 
determining the fate of the injected 5’-AMP was to assess the role of adenosine in 
initiating DH. Experiments with mice lacking the enzyme 5’-ectonucleotidase/CD73 
133 
  
or the adenosine receptors demonstrated the animals were able to enter DH 
similarly to wild-type mice. Results from these independent genetic approaches 
indicated that the dephosphorylation of 5’-AMP to adenosine outside the cell is not 
required to initiate the DH model. 
Next, the focus turned to identifying whether 5’-AMP was the molecule that 
initiates DH. Experiments showed that mice injected with 5’-CMP and 5’-GMP did 
not experience a decline in metabolic rate. It was found that adenosine, ATP and 
ADP do induce a decline in VO2 but it is more transitory and had slower kinetics 
than in mice given 5’-AMP. This can be explained because the adenine nucleotides 
are being modified into 5’-AMP in vivo. In contrast adenosine had similar kinetics to 
5’-AMP but the effect on VO2 is very transient.  In addition, adenosine has low 
solubility in water and it has a very short half-life of less than 10 seconds in serum. 
(36). These factors likely account for the reason mice injected with adenosine did 
not enter DH, as it is rapidly degraded before DH could take hold. It is possible that 
given a continuous transfusion, adenosine could induce DH. In comparison with 
mice injected with 5’-AMP, the VO2 declined less rapidly in mice given cAMP, and 
ATP. Other investigators have observed similar results with ADP and ATP given at 
similar concentration. Together, these results indicate that 5’-AMP itself is 
responsible for initiating the DH state.  
Analysis of 14C signal in perfused tissues after injection of 14C-AMP in a 
mouse confirmed what had already been found in published data (39). The 
radiolabel is most concentrated in the blood and in vascular organs such as heart, 
lung and kidney, and does not concentrate in the brain. In addition, the Mathews 
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group had found that 5’-[11C]-AMP uptake in blood changed the ADP/ATP ratio, 
which would occur by the adenylate equilibrium, AMP + ATP  2ADP (39). In 
vitro 14C-AMP uptake experiments in erythrocytes isolated from wild-type and CD73 
deficient mice and visualized with thin layer chromatography showed that 5’-AMP is 
taken up in the cells and metabolism favors formation of ADP, which corresponds to 
the adenylate equilibrium. This information, along with HPLC analysis of blood 
extracts from mice given 5’-AMP indicated that the 5’-AMP is taken up in the 
erythrocytes and forces the adenylate equilibrium to increase ADP production, thus 
reducing ATP levels. Evidence from the metabolomics study and other metabolic 
analysis of mice treated with 5’-AMP suggested that glycolysis is slowed in mice in 
DH. Glucose is elevated and lactate is decreased. These data taken together led to 
the hypothesized model for the initiation step of the DH model (Figure 32). 
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Figure 32: Proposed model for initiation of 5’-AMP – induced deep hypometabolism 
This research was originally published in The Journal of Biological Chemistry. 
Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. 
Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for 
Biochemistry and Molecular Biology. 
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The first step of the glycolytic pathway requires ATP for conversion of 
glucose to glucose-6-phosphate, catalyzed by hexokinase (14). If intracellular ATP 
levels decrease, then glycolysis would slow and glucose would build up and less 
lactate, the end product, would be formed. Previous investigators have performed 
metabolic modeling that indicates when glycolysis slows an increase in 2,3-BPG 
production occurs in order to stabilize the ATP levels in erythrocytes. Therefore, a 
small variation in the intracellular ATP level could cause a great increase in 2,3-
BPG production in the erythrocyte (40).   
2,3-BPG is known to allosterically regulate hemoglobin’s affinity for oxygen 
(16). It binds strongly to deoxyhemoglobin, but binds weakly to oxyhemoglobin (14, 
40). Therefore, increased 2,3-BPG in the erythrocytes of an animal injected with 5’-
AMP would cause less oxygen transport to tissues. Evidence of this is seen in the 
physiological observations and measurements of animals injected with 5’-AMP. The 
Phase I response, in which VO2 rapidly and dramatically decreases, may be a 
reflection of the sudden reduction in oxygen transport to tissues. Also, the allosteric 
nature of 2,3-BPG regulation of hemoglobin affinity for oxygen could be the reason 
that a range of doses of 5’-AMP all trigger a Phase I response of similar magnitude. 
The elevated 2,3-BPG levels are further confirmed by the spectral analysis of blood 
taken 10 minutes after 5’-AMP injection showing increased deoxyhemoglobin and 
decreased oxyhemoglobin levels. The reduced oxygen transport to the tissues 
could trigger a whole body physiological response to lower metabolic rate. If this 
occurs in a cooler environment, then the body will lose heat and be unable to 
maintain euthermic Tb due to the lower metabolic rate. Tb will continue to decrease 
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toward the Ta. During the Phase II response, in which Tb gradually decreases as 
VO2 continues to decline, the body would not require as much oxygen, which in turn 
allows the VO2 to drop further. As demonstrated by experiments measuring time to 
recovery from DH in different Ta, the correct Ta will allow the animal to maintain the 
DH state, and the animal’s Tb and the Ta will be in equilibrium. If the animal in DH is 
gradually rewarmed, the VO2 will increase, causing arousal from DH. However, 
there is much variation in the how long mice maintained in the same Ta remain in 
DH, which suggests there are still factors to be determined that control the length of 
time in DH.  
Discussion of erythrocyte as initiation site for 5’-AMP – induced deep 
hypometabolism 
Metabolic rate in small mammals can be pharmacologically reduced by 
treatment with 2-deoxyglucose or hydrogen sulfide gas (H2S) (22, 55). While it is not 
understood how these metabolic inhibitors reduce Tb, the effects on erythrocytes 
are known. Erythrocytes metabolize inhaled H2S gas in the following reaction: HbO2 
+ H2S  2S + Hb + H2O, and oxygen levels are greatly decreased (23). In the case 
of 2-deoxyglucose, a known inhibitor of hexokinase, the first step in glycolysis is 
stopped. Since erythrocytes rely primarily on glycolysis to produce ATP, the cellular 
level of ATP would decrease. The role of the erythrocyte in 2-deoxyglucose 
induction of torpor is further suggested because a different metabolic inhibitor, β-
mercaptoacetate, does not induce torpor in small mammals. β-mercaptoacetate 
inhibits β-oxidation, a function of mitochondria. Erythrocytes lack mitochondria (14, 
55). Further evidence of the role of the erythrocyte is that previous investigators 
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have used exsanguination to reduce Tb in mammals (56, 57). Also, hypoxia is 
known to cause hypothermia (58). In summary, the results suggest the erythrocyte 
may be the site for the initiation of many different methods of reducing metabolic 
rate in mammals. 
Discussion of AMPD3 deficient mice phenotype and AMPD3 role in 5’-AMP-
induced model of deep hypometabolism 
The determination that the erythrocyte is the site of initiation of the DH model 
led to studies to determine whether AMP deaminase, specifically in the erythrocyte, 
plays a role in the control of the DH model. AMPD3 deficient mice had undetectable 
AMPD activity in erythrocytes, and reduced activity in heart tissue as evident from 
the lack of IMP formation in the erythrocyte lysates.  
AMPD3 deficient mice remaining in Phase II response longer than wild-type 
mice after lower dosage of 5’-AMP indicates that the AMPD catabolism of 5’-AMP, 
specifically in the erythrocyte, is important in the 5’-AMP – induced DH model. 
Future investigations will test whether AMPD3/CD73 deficient mice injected with 
lower dose 5’- AMP have an even more dramatic response than the AMPD3 
deficient mice. Lack of 5’-AMP catabolism outside the cell by CD73, combined with 
a lack of 5’-AMP catabolism inside the cell by AMPD3 could possibly cause a low 
5’-AMP dose to be effectively higher in these mice. 
We observed that the VO2 was similar in wild-type, heterozygous and 
homozygous AMPD3 deficient mice. A similar glucose level in fasting blood glucose 
experiments also suggested the AMPD3 deficient mice have similar metabolic 
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phenotype to wild-type, at least under normal metabolic state. However, analysis of 
the Tb of telemetry implanted AMPD3 deficient mice showed a lower Tb in constant 
22°C Ta, and some have difficulty maintaining Tb under moderate metabolic stress.  
Observation of the lower Tb phenotype led to the question of how the Tb 
could be reduced without such apparent decrease in metabolic rate. Classically, Tb 
regulation is controlled by the hypothalamus. The AMPD3 deficient mice are lacking 
the AMPD activity only in the erythrocyte, so the hypothalamic thermoregulation 
may not be directly affected by this genetic mutation.  Rather, we speculate that 
when under metabolic stress, delivery of oxygen to the tissue is important for 
maintaining Tb. If the function of the erythrocyte is somehow impaired, the delivery 
of oxygen to tissues may be inadequate. Hypoxia is known to decrease 
thermogenesis (59). Investigators have found that brown adipose tissue of rats 
maintained in hypoxic conditions since birth had greatly reduced uncoupling protein 
content (59). Also, studies in CD-1 mice demonstrated that chronic hypoxia reduces 
capacity for non-shivering thermogenesis and decreases the relative contents of 
uncoupling protein 1 in brown adipose tissue and uncoupling protein 3 in 
gastrocnemius muscle (15). Interestingly, chronically hypoxic CD-1 mice had a 
decline in Tb to 35°C when placed in a 4°C Ta, although their VO2 increased similarly 
to that of normoxic control mice. In contrast, the normoxic control mice maintained 
euthermic Tb of 37°C in this acute metabolic stress condition (15).  These findings 
correspond to our observations in AMPD3 deficient mice. When Ta was reduced 
from 22°C to 18°C, some AMPD3 deficient mice displayed inability to maintain Tb 
despite a similar increase in VO2 to wild-type mice. Further studies will investigate 
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the possibility that AMPD3 deficiency in mice impairs erythrocyte function, causing 
mild chronic hypoxia, and consequently undermining non-shivering thermogenesis 
capacity. Analysis of the brown adipose tissue and muscle uncoupling protein 
content, and oxygenation status in the erythrocyte and tissues will give insight into 
this question. 
Possible explanations for increased ATP and ADP in erythrocytes of AMPD3 
deficient mice 
Analysis of the ATP, ADP and 5’-AMP levels in the erythrocyte lysate 
extracts of the AMPD3 deficient mice showed that ATP and ADP are increased 3-
fold. This corresponds with published data describing 150% of normal level of ATP 
in affected cells of humans with AMPD3 deficiency (51). In addition, analysis of 
aged erythrocytes from rabbits demonstrate that erythrocyte AMP deaminase 
activity reaches a minimum after 40 days in the 120 day erythrocyte lifespan. The 
aged erythrocytes have elevated levels of ATP (60).  
It has not been explained in the literature how ATP levels can rise when 
erythrocytes lack AMPD3 to deaminate 5’-AMP to IMP. Cytosolic nucleotidase 
dephosphorylates 5’-AMP to adenosine, but adenosine kinase which 
phosphorylates adenosine back to 5’-AMP has a much lower Km than adenosine 
deaminase, so phosphorylation of adenosine to 5’-AMP is favored. Thus, if 
catabolism of 5’-AMP to IMP is blocked, then the adenine nucleotide pool would be 
increased. By the adenylate equilibrium AMP + ATP  2 ADP, if 5’-AMP levels 
rise, then to balance the equilibrium, ADP would have to increase and ATP should 
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decrease. Alternatively, the rise in ADP could be balanced by a rise in ATP and a 
decline in 5’-AMP, which is what was observed.  
Cytosolic nucleotidase can dephosphorylate AMP to adenosine, but then in 
the next step adenosine kinase has a much lower Km than adenosine deaminase, 
so phosphorylation of adenosine to AMP is favored (Figure 33) (14, 16, 60).  
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Figure 33: Km values for metabolism of adenine nucleotides and nucleosides inside 
the cell 
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AMP formation would be favored until the substrate level was high enough to 
overcome the lower Km of adenosine kinase, and allow adenosine deaminase to 
convert some of the adenosine to inosine. This would cause a build-up of AMP, 
which can be phosphorylated to ADP and ATP.  
Possible role of Na+/K+ pump 
Physiological concentration of 5’-AMP is much lower than ATP and ADP. In 
erythrocytes, 5’-AMP concentration is about 14 µM, compared to 1,797 µM for ATP 
and 227 µM for ADP (61). Maintaining the relative concentrations of ATP, ADP and 
5’-AMP inside the cell is essential.  
One possible reason for the adenine nucleotide pool in AMPD3 deficient 
erythrocytes to be maintained in ATP/ADP rather than 5’-AMP/ADP is the 
physiological need of the erythrocytes. The observed increase in ATP and ADP 
levels in the erythrocyte lysate are within the normal ADP/ATP ratio. Maintenance of 
this ratio would promote proper function of the Na+/K+ pump. The Na+/K+ pump, also 
called the Na+/K+– ATPase, uses active transport to export Na+ and import K+, using 
the energy from dephosphorylation of ATP to ADP (62). One of its functions is to 
maintain the osmotic pressure within the cell, which is necessary to maintain cell 
shape. Previous studies have investigated the effect of changing the ADP/ATP ratio 
on the activity of the Na+/K+ pump in resealed erythrocyte ghosts. The investigators 
used phosphoarginine or phosphocreatine-based systems to enzymatically 
regenerate ADP or ATP to vary ADP/ATP ratios. Using an adenylate kinase 
inhibitor, they prevented the adenylate equilibrium from re-equilibrating the AMP, 
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ADP and ATP to normal ratios. Changes in ADP/ATP ratio affected the rate of ion 
exchange (63). This could have significant impact on the homeostasis of intact 
erythrocytes. 
The energy homeostasis in erythrocytes of AMPD3 deficient mice may be 
altered due to increased adenine nucleotide pools. This could cause an inability of 
the erythrocytes to properly transport oxygen to tissues, which may result in the 
decreased Tb phenotype. Further analysis is needed to understand this phenotype. 
Conclusion 
In summary, this dissertation describes a novel method for inducing a deep 
hypometabolic state in mammals, induced by uptake and metabolism of a natural 
molecule, 5’-AMP. Biochemical analyses and genetic approaches have provided 
clues into the initiation and control of the model. This work adds to understanding of 
the mechanisms involved in the 5’-AMP induced model of deep hypometabolism. 
Possible future clinical application of the model in humans will require a deeper 
comprehension of the mechanisms underlying this model. 
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